ArticleMolecular therapy. Oncology2026

AAV immuno-gene therapy platform delivering vectorized cytokines defines a new modality for high-grade glioma treatment.

Akela Kuwahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.